#1
#1 out of 1
business8h ago
Missouri AG files lawsuit against 19 pharmacy companies for alleged insulin pricing scheme
- Missouri files a lawsuit against 19 PBMs and drug manufacturers over insulin pricing and alleged fraud.
- The Missouri AG claims the alleged scheme led to rapid insulin price increases for uninsured diabetics over 15 years.
- Missouri lawmakers are considering new PBM regulations to improve transparency and pricing.
- The lawsuit highlights insulin affordability concerns for uninsured Missourians.
- The complaint names major PBMs and manufacturers including Express Scripts, CVS Health, Eli Lilly, Novo Nordisk and Sanofi.
- Attorney General Hanaway frames insulin pricing as a barrier to affordable care.
- The Missouri Pharmacy Business Council commented on broader PBM abuses in response to the suit.
- The suit cites rapid price increases for uninsured diabetics in Missouri.
- The complaint names the case as part of a broader regulatory push on PBMs in Missouri.
- The filing occurred in St. Louis County Circuit Court on January 15.
Vote 0